Annual Accounts Receivable
$181.51 M
+$42.10 M+30.20%
31 December 2023
Summary:
Chemed annual accounts receivable is currently $181.51 million, with the most recent change of +$42.10 million (+30.20%) on 31 December 2023. During the last 3 years, it has risen by +$54.66 million (+43.09%). CHE annual accounts receivable is now at all-time high.CHE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$196.48 M
+$11.52 M+6.23%
30 September 2024
Summary:
Chemed quarterly accounts receivable is currently $196.48 million, with the most recent change of +$11.52 million (+6.23%) on 30 September 2024. Over the past year, it has increased by +$28.45 million (+16.93%). CHE quarterly accounts receivable is now at all-time high.CHE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHE Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.2% | +16.9% |
| 3 y3 years | +43.1% | +66.2% |
| 5 y5 years | +51.9% | +71.6% |
CHE Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +43.1% | at high | +67.5% |
| 5 y | 5 years | at high | +51.9% | at high | +87.6% |
| alltime | all time | at high | +1164.8% | at high | +1376.2% |
Chemed Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $196.48 M(+6.2%) |
| June 2024 | - | $184.96 M(+4.3%) |
| Mar 2024 | - | $177.33 M(-2.3%) |
| Dec 2023 | $181.51 M(+30.2%) | $181.51 M(+8.0%) |
| Sept 2023 | - | $168.03 M(+39.7%) |
| June 2023 | - | $120.31 M(-21.8%) |
| Mar 2023 | - | $153.82 M(+10.3%) |
| Dec 2022 | $139.41 M(+1.6%) | $139.41 M(+14.6%) |
| Sept 2022 | - | $121.66 M(-10.9%) |
| June 2022 | - | $136.56 M(+16.4%) |
| Mar 2022 | - | $117.32 M(-14.5%) |
| Dec 2021 | $137.22 M(+8.2%) | $137.22 M(+16.1%) |
| Sept 2021 | - | $118.19 M(-4.2%) |
| June 2021 | - | $123.33 M(+17.7%) |
| Mar 2021 | - | $104.75 M(-17.4%) |
| Dec 2020 | $126.85 M(-11.8%) | $126.85 M(+14.4%) |
| Sept 2020 | - | $110.84 M(-16.3%) |
| June 2020 | - | $132.49 M(-1.6%) |
| Mar 2020 | - | $134.69 M(-6.3%) |
| Dec 2019 | $143.83 M(+20.4%) | $143.83 M(+25.6%) |
| Sept 2019 | - | $114.48 M(-15.9%) |
| June 2019 | - | $136.11 M(+13.8%) |
| Mar 2019 | - | $119.58 M(+0.1%) |
| Dec 2018 | $119.50 M(+5.1%) | $119.50 M(+9.6%) |
| Sept 2018 | - | $109.00 M(-8.6%) |
| June 2018 | - | $119.21 M(+7.1%) |
| Mar 2018 | - | $111.33 M(-2.0%) |
| Dec 2017 | $113.65 M(-13.9%) | $113.65 M(+24.2%) |
| Sept 2017 | - | $91.48 M(-22.4%) |
| June 2017 | - | $117.91 M(+7.5%) |
| Mar 2017 | - | $109.73 M(-16.9%) |
| Dec 2016 | $132.02 M(+24.2%) | $132.02 M(+53.5%) |
| Sept 2016 | - | $86.01 M(-13.1%) |
| June 2016 | - | $98.95 M(-30.8%) |
| Mar 2016 | - | $143.04 M(+34.6%) |
| Dec 2015 | $106.26 M(-14.7%) | $106.26 M(-14.1%) |
| Sept 2015 | - | $123.67 M(+3.8%) |
| June 2015 | - | $119.12 M(-18.3%) |
| Mar 2015 | - | $145.76 M(+17.0%) |
| Dec 2014 | $124.61 M(+35.8%) | $124.61 M(-5.8%) |
| Sept 2014 | - | $132.34 M(+43.6%) |
| June 2014 | - | $92.15 M(-20.7%) |
| Mar 2014 | - | $116.15 M(+26.6%) |
| Dec 2013 | $91.77 M(-1.7%) | $91.77 M(+14.5%) |
| Sept 2013 | - | $80.12 M(+4.9%) |
| June 2013 | - | $76.36 M(-40.0%) |
| Mar 2013 | - | $127.22 M(+36.3%) |
| Dec 2012 | $93.33 M | $93.33 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $101.15 M(+23.6%) |
| June 2012 | - | $81.81 M(-26.1%) |
| Mar 2012 | - | $110.66 M(+42.0%) |
| Dec 2011 | $77.92 M(-31.0%) | $77.92 M(-30.9%) |
| Sept 2011 | - | $112.72 M(-4.7%) |
| June 2011 | - | $118.28 M(+27.3%) |
| Mar 2011 | - | $92.91 M(-17.8%) |
| Dec 2010 | $113.00 M(+111.4%) | $113.00 M(+6.9%) |
| Sept 2010 | - | $105.69 M(+3.9%) |
| June 2010 | - | $101.74 M(+16.4%) |
| Mar 2010 | - | $87.41 M(+63.5%) |
| Dec 2009 | $53.46 M(-45.5%) | $53.46 M(-49.9%) |
| Sept 2009 | - | $106.67 M(+2.4%) |
| June 2009 | - | $104.12 M(-3.0%) |
| Mar 2009 | - | $107.36 M(+9.5%) |
| Dec 2008 | $98.08 M(-3.1%) | $98.08 M(+11.2%) |
| Sept 2008 | - | $88.21 M(-13.0%) |
| June 2008 | - | $101.40 M(+16.5%) |
| Mar 2008 | - | $87.00 M(-14.0%) |
| Dec 2007 | $101.17 M(+8.7%) | $101.17 M(+23.8%) |
| Sept 2007 | - | $81.72 M(-18.2%) |
| June 2007 | - | $99.87 M(+17.2%) |
| Mar 2007 | - | $85.21 M(-8.5%) |
| Dec 2006 | $93.09 M(+2.2%) | $93.09 M(-10.7%) |
| Sept 2006 | - | $104.24 M(+9.9%) |
| June 2006 | - | $94.83 M(+32.0%) |
| Mar 2006 | - | $71.86 M(-21.1%) |
| Dec 2005 | $91.09 M(+40.9%) | $91.09 M(+7.8%) |
| Sept 2005 | - | $84.47 M(-0.6%) |
| June 2005 | - | $84.97 M(+3.8%) |
| Mar 2005 | - | $81.88 M(+26.6%) |
| Dec 2004 | $64.66 M(+350.6%) | $64.66 M(-9.5%) |
| Sept 2004 | - | $71.48 M(+21.1%) |
| June 2004 | - | $59.03 M(-8.2%) |
| Mar 2004 | - | $64.31 M(+348.1%) |
| Dec 2003 | $14.35 M(-2.0%) | $14.35 M(+7.8%) |
| Sept 2003 | - | $13.31 M(-12.4%) |
| June 2003 | - | $15.19 M(+3.4%) |
| Mar 2003 | - | $14.69 M(+0.3%) |
| Dec 2002 | $14.64 M(-3.2%) | $14.64 M(-0.9%) |
| Sept 2002 | - | $14.77 M(-70.9%) |
| June 2002 | - | $50.79 M(-0.6%) |
| Mar 2002 | - | $51.08 M(+237.7%) |
| Dec 2001 | $15.13 M(-72.3%) | $15.13 M(-70.5%) |
| Sept 2001 | - | $51.29 M(+0.8%) |
| June 2001 | - | $50.90 M(-4.1%) |
| Mar 2001 | - | $53.10 M(-2.7%) |
| Dec 2000 | $54.57 M(-37.6%) | $54.57 M(-37.6%) |
| Dec 1994 | $87.50 M | $87.50 M |
FAQ
- What is Chemed annual accounts receivable?
- What is the all time high annual accounts receivable for Chemed?
- What is Chemed annual accounts receivable year-on-year change?
- What is Chemed quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Chemed?
- What is Chemed quarterly accounts receivable year-on-year change?
What is Chemed annual accounts receivable?
The current annual accounts receivable of CHE is $181.51 M
What is the all time high annual accounts receivable for Chemed?
Chemed all-time high annual accounts receivable is $181.51 M
What is Chemed annual accounts receivable year-on-year change?
Over the past year, CHE annual accounts receivable has changed by +$42.10 M (+30.20%)
What is Chemed quarterly accounts receivable?
The current quarterly accounts receivable of CHE is $196.48 M
What is the all time high quarterly accounts receivable for Chemed?
Chemed all-time high quarterly accounts receivable is $196.48 M
What is Chemed quarterly accounts receivable year-on-year change?
Over the past year, CHE quarterly accounts receivable has changed by +$28.45 M (+16.93%)